Solace Pharmaceuticals discovers and develops innovative treatments for pain by focusing their research and development programs on exploiting novel biological understanding of disease targets that play a role in the pathogenesis of pain and that have disease-modifying potential in two key areas: modulating the activity of glial cells and intervening in the tetrohydrobiopterin pathway.